T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Driven Brands
DRVN
$2.12B
| $243K | ﹤0.01% |
19,081
+5,257
| +38% | +$66.5K |
|
|
DX
2502
Dynex Capital
DX
$3.23B
| $243K | ﹤0.01% |
20,344
+4,085
| +25% | +$49.1K |
|
2503
Ring Energy
REI
$349M
| $243K | ﹤0.01% |
143,351
+10,356
| +8% | +$19K |
|
|
FBMS
2504
DELISTED
The First Bancshares, Inc.
FBMS
| $243K | ﹤0.01% |
9,327
+530
| +6% | +$13.1K |
|
|
RVNC
2505
DELISTED
Revance Therapeutics, Inc.
RVNC
| $243K | ﹤0.01% |
94,453
+25,092
| +36% | +$85.7K |
|
|
CNSL
2506
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $243K | ﹤0.01% |
55,019
+2,007
| +4% | +$8.68K |
|
|
ETWO
2507
DELISTED
E2open Parent Holdings
ETWO
| $242K | ﹤0.01% |
53,889
+5,044
| +10% | +$22.7K |
|
|
HDSN
2508
Hudson Technologies
HDSN
$239M
| $242K | ﹤0.01% |
27,520
-2,683
| -9% | -$26K |
|
2509
United States Lime & Minerals
USLM
$3.37B
| $241K | ﹤0.01% |
+3,300
| New | +$220K |
|
|
CCRN
2510
DELISTED
Cross Country Healthcare
CCRN
| $240K | ﹤0.01% |
17,279
+640
| +4% | +$10.1K |
|
2511
First Mid Bancshares
FMBH
$1.39B
| $240K | ﹤0.01% |
7,282
+919
| +14% | +$28.9K |
|
2512
KRONOS Worldwide
KRO
$996M
| $240K | ﹤0.01% |
19,068
+601
| +3% | +$7.59K |
|
|
ESPR
2513
DELISTED
Esperion Therapeutics
ESPR
| $239K | ﹤0.01% |
107,492
+72,092
| +204% | +$170K |
|
2514
HCI Group
HCI
$2.32B
| $239K | ﹤0.01% |
2,587
+509
| +24% | +$53K |
|
2515
Bally's
BALY
$660M
| $238K | ﹤0.01% |
19,878
-254
| -1% | -$3.25K |
|
2516
Byline Bancorp
BY
$1.78B
| $236K | ﹤0.01% |
+9,918
| New | +$221K |
|
2517
iShares Russell 3000 ETF
IWV
$20.6B
| $236K | ﹤0.01% |
764
| – | – |
|
|
CDMO
2518
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $236K | ﹤0.01% |
33,032
+2,733
| +9% | +$20.9K |
|
2519
Marcus & Millichap
MMI
$1.2B
| $235K | ﹤0.01% |
7,429
+634
| +9% | +$20.5K |
|
|
SEI
2520
Solaris Energy Infrastructure
SEI
$3.94B
| $234K | ﹤0.01% |
27,182
-7,504
| -22% | -$65.6K |
|
2521
Artesian Resources
ARTNA
$369M
| $233K | ﹤0.01% |
6,611
-2,836
| -30% | -$103K |
|
2522
Beyond Meat
BYND
$210M
| $233K | ﹤0.01% |
34,638
+1,534
| +5% | +$10.9K |
|
2523
Rush Street Interactive
RSI
$2.85B
| $233K | ﹤0.01% |
24,211
+5,550
| +30% | +$44.4K |
|
2524
SIGA Technologies
SIGA
$207M
| $232K | ﹤0.01% |
30,437
+1,257
| +4% | +$10.2K |
|
2525
Chegg
CHGG
$89.3M
| $231K | ﹤0.01% |
72,897
+907
| +1% | +$4.51K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.